Tyler is focused on the organization of the health care system with a particular interest in the evolution of changes in the organization and financing of physician practices and providers of end-of-life and long-term care. As principal investigator on several grants, from funders such as the National Institute on Aging and Arnold Ventures, his team is in the process of examining physician and long-term care organization, financing, and behavior within the U.S. health delivery system. Currently, his research interests are related to mergers and acquisitions of physician practices, hospices, and nursing homes by various types of institutional investment. His research is published in the New England Journal of Medicine, JAMA Internal Medicine, and Health Affairs, and he has received coverage from The New York Times, Washington Post, and The New Yorker Magazine. Furthermore, his research has received substantial attention from policymakers, including The White House, Senate Finance Committee, and the House Ways and Means Committee. He also teaches in the Executive M.B.A./M.S. Healthcare Leadership program at Cornell University.

Dr. Mashni is currently the VP/Chief Pharmacy Officer for the Mount Sinai Health System in New York. In this role, Sue oversees pharmacy practice at the seven Mount Sinai hospitals, as well as retail, clinic and specialty pharmacies at Mount Sinai. Previous to this role, Sue was the Chief Pharmacy Officer of Mercy Health system headquartered in Cincinnati, Ohio overseeing pharmacy practice in 23 hospitals, over 25 retail pharmacies and 20+ ambulatory pharmacy practice sites in Mercy Health, in Ohio and Kentucky. Additionally, Dr. Mashni oversaw a Population Health Pharmacy team, Mercy’s Specialty Pharmacy, Mercy’s Mail Order facility and a team that helps to manage Mercy’s PBM relationship for employee health. She regularly presents at national meetings on medication management, standardization of formularies as well as the pharmacist’s role in the electronic health record. Dr. Mashni is also an Adjunct Professor at UC College of Pharmacy and serves on several UC College of Pharmacy committees. Sue serves on several national advisory boards, including Wolters Kluewer and Epic Pharmacy Advisory Boards and is on the Board of the St. Vincent de Paul Charitable Pharmacy in Cincinnati.

Dr. Zimet is a clinical psychologist and Professor Emeritus of Pediatrics and Psychiatry at Indiana University School of Medicine and the founder of the Indiana University Center for HPV Research. Since 2017, he has served on the Board of Directors for the UNITY Consortium, a non-profit 501 (c)(3) organization that brings together diverse groups that share a common and passionate interest in adolescent and young adult health with a focus on prevention and immunization. Dr. Zimet’s research has encompassed behavioral, social, and policy-based determinants of vaccination. His studies have focused on adolescents, adults, parents, and health care providers and have included evaluations of vaccine communication intervention strategies.

Josh Morrison is a serial social entrepreneur and aspiring effective altruist who has founded 1Day Sooner, Waitlist Zero, and the Rikers Debate Project. His work — in the fields of clinical trials, living organ donation, and criminal justice reform — focuses on empowering particular identity groups (research participants, kidney donors, and incarcerated people) to improve decision-making processes so as to achieve impactful policy. His projects have been covered globally in outlets such as the New York Times, CNN, the Financial Times, the BBC, Der Spiegel, Asahi Shimbun, and the South China Morning Post. His writing has been published in the Washington Post, the American Journal of Bioethics, Clinical Infectious Disease, Vaccine, Risk Analysis, Vox, STAT News, and BMJ Opinion.

Xan was recently the Management Officer of the National Center for Immunization and Respiratory Diseases at the Centers for Disease Control and Prevention.  In that role he had operational accountability for billions of dollars in public funding and a workforce of approximately 2,000 employees and contractors.  Xan was an essential member of the executive team responsible for administering programs that vaccinate millions of children and adults, mitigate the impacts of outbreaks, epidemics and pandemics (which includes the CDC’s response to COVID-19), and build surveillance networks that detect and control respiratory pathogens.  He oversaw the allocation of supplemental emergency resources, organized staffing and operational activities, and led a cross-program team that developed implementation guidance for state and local jurisdictions and public health partners receiving CDC funding for COVID-19 vaccine and equity programs. He’s currently a student in Cornell’s EMBA and MS in Healthcare Leadership program (class of 2024).